PrintyMed: Strategic-Technological Analysis
15 pages · PDF · 22 August 2025 · Licensed single-user copy, watermarked to the buyer
€299 excl. VAT — EU VAT calculated at checkout (VAT ID accepted for reverse charge); invoice issued after payment
One click to Stripe — guest checkout, no account. Your download appears on the confirmation page and arrives by e-mail right after payment (link valid 72 hours, up to 5 downloads).
About this report
Introduction: In the evolving arena of European biotechnology and advanced materials, one Latvian spin-off stands out by harnessing an unlikely muse – the spider. PrintyMed has developed a proprietary biomimetic spider silk produced by engineered bacteria .
This novel material combines exceptional strength and elasticity with biocompatibility, making it suitable for medical implants and tissue engineering. The company’s founding team – combining expertise in organic chemistry, medicine and business – claims an exclusive license to this spider-silk platform .
Key questions this report answers
- How does PrintyMed produce biomimetic spider silk using engineered bacteria, and what strength, elasticity and biocompatibility does it offer?
- What medical-implant and tissue-engineering applications does the spider-silk platform enable?
- As a Latvian spin-off holding an exclusive platform license, how is PrintyMed positioned in European biotech and advanced materials?
- What capability gaps, IP and scaling dependencies affect PrintyMed's spider-silk platform?
Inside this report
- Executive Summary
Who it's for
Investors screening PrintyMed, competitors and partners assessing their position, and analysts who need a sourced, structured account of the entity and its technology.
Related reports
Methodology, format & delivery
DFM reports are built from primary and official sources — TED procurement notices, CORDIS and the EU Funding & Tenders Portal, EIB operations, the NATO Innovation Fund portfolio, SIPRI data, official budget documents and company disclosures — read together with the underlying legal texts. Sources are cited in the document; it reflects them as of its publication date (22 August 2025). You receive a 15-page PDF, watermarked to you on every page, delivered on the confirmation page and by e-mail immediately after checkout (personal link valid 72 hours, up to 5 downloads). Guest checkout, single-user licence — Terms of Sale.
Related on DFM
More Tactical reports · Synthetic Biology · Military Medical Tech · All reports
Prefer unlimited access?
Prefer unlimited access? Every report like this is included in the DFM Analysis subscription. See plans →